Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in Close of $11 Million Underwritten Public Offering and NASDAQ Uplisting By Sichenzia Ross Ference LLP | January 15, 2021 Lexaria Bioscience Corp. $11,000,000 Common Stock and Warrants January 2021 Read More
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement By Sichenzia Ross Ference LLP | May 10, 2020 Lexaria Bioscience Corp. $2,000,000 Common Stock and Warrants May 2020 Read More
